Home / Investors / Financial Information / Five-Year Financial Summary

Five-Year Financial Summary

In millions, except per share amounts 2018 2017 2016 2015 2014
Statement of operations data:
Total revenues(1) $ 194,579 $ 184,786 $ 177,546 $ 153,311 $ 139,382
Operating income(1)(2)(3) 4,021 9,538 10,386 9,496 8,837
Income (loss) from continuing operations (596) 6,631 5,320 5,230 4,645
Net income (loss) attributable to CVS Health ($594) $6,622 $5,317 $5,237 $4,644
Per common share data:
Basic earnings per common share:
Income (loss) from continuing operations attributable to CVS Health $ (0.57) $ 6.48 $ 4.93 $ 4.65 $ 3.98
Income (loss) from discontinued operations attributable to CVS Health $ 0.00 $ (0.01) $ 0.00 $ 0.01 $ 0.00
Net income (loss) attributable to CVS Health $ (0.57) $ 6.47 $ 4.93 $ 4.66 $ 3.98
Diluted earnings per common share:
Income (loss) from continuing operations attributable to CVS Health $ (0.57) $ 6.45 $ 4.91 $ 4.62 $ 3.96
Income (loss) from discontinued operations attributable to CVS Health $ 0.00 $ (0.01) $ 0.00 $ 0.01 $ 0.00
Net income (loss) attributable to CVS Health $ (0.57) $ 6.44 $ 4.90 $ 4.63 $ 3.96
Cash dividends per common share $ 2.00 $ 2.00 $ 1.70 $ 1.40 $ 1.10
Balance sheet and other data:
Total assets $ 196,456 $ 95,131 $ 94,462 $ 92,437 $ 73,202
Long-term debt $ 71,444 $ 22,181 $ 25,615 $ 26,267 $ 11,630
Total shareholders’ equity $ 58,543 $ 37,695 $ 36,834 $ 37,203 $ 37,963
Number of stores (at end of year) 9,967 9,846 9,750 9,681 7,866

(1) Effective for the fourth quarter of 2018, interest income was reclassified from interest expense, net, to net investment income within revenues to conform with insurance company related presentation. Accordingly, a retrospective reclassification of $21 million, $20 million, $21 million and $15 million was made for years ended December 31, 2017, 2016, 2015 and 2014, respectively, to increase revenues and increase interest expense.

(2) As of January 1, 2017, the Company adopted Accounting Standards Update ("ASU") 201-07, Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, which resulted in a retrospective reclassification of $28 million, $21 million and $23 million of net benefit costs from operating expenses to other expense in the years ended December 31, 2016, 2015 and 2014, respectively.

(3) The condensed consolidated statements of operations for the years ended December 31, 2017 and 2016 have been retrospectively adjusted to reflect a change to the Company's cost allocation methodology effective January 1, 2018